Abstract  Description  Claims  Drawing  Search report  Cited references 

WO2014086364A   [0009] 
WO2013167130A   [0009] 
US7026282B   [0021] 

Review of Neurosurgical Fluorescence Imaging Methodologies   [0042] 
Positive margin rates following breast-conserving surgery for stage I-III breast cancer: palpable versus nonpalpable tumors   [0042] 
Fluorescence-guided surgery with live molecular navigation - a new cutting edge   [0042] 
Image-guided cancer surgery using near-infrared fluorescence   [0042] 
Quantitative PET of human urokinase-type plasminogen activator receptor with 64Cu-DOTA-AE105: implications for visualizing cancer invasion   [0042] 
68Ga-labeling and in vivo evaluation of a uPAR binding DOTA- and NODAGA-conjugated peptide for PET imaging of invasive cancers   [0042] 
First 18F-labeled ligand for PET imaging of uPAR: In vivo studies in human prostate cancer xenografts   [0042] 
Imaging of Urokinase-Type Plasminogen Activator Receptor Expression Using a 64Cu-Labeled Linear Peptide Antagonist by microPET   [0042] 
Preclinical Comparison of Near-Infrared-Labeled Cetuximab and Panitumumab for Optical Imaging of Head and Neck Squamous Cell Carcinoma   [0042] 
Intraoperative near-infrared fluorescence imaging of colorectal metastases targeting integrin αvβ3 expression in a syngeneic rat model   [0042] 
In vivo Molecular Imaging of Cancer with a Quenching Near-Infrared Fluorescent Probe Using Conjugates of Monoclonal Antibodies and Indocyanine Green   [0042] 
Dual-Modality Molecular Imaging Using Antibodies Labeled with Activatable Fluorescence and a Radionuclide for Specific and Quantitative Targeted Cancer Detection   [0042] 
Short PEG-Linkers Improve the Performance of Targeted, Activatable Monoclonal Antibody-Indocyanine Green Optical Imaging Probes   [0042] 
Peer-Review Reports   [0042] 
Real-time near-infrared fluorescence guided surgery in gynecologic oncology: A review of the current state of the art   [0042]